NC
MRK icon

Northpointe Capital’s Merck MRK Stock Holding History

Northpointe Capital’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		$3.54M Sell
44,035
-22,322
-34% -$1.79M 1.37% 30
2019
Q2 		$5.31M Sell
66,357
-43,337
-40% -$3.32M 1.69% 12
2019
Q1 		$8.71M Sell
109,694
-588
-0.5% -$44K 2.74% 4
2018
Q4 		$8.04M Sell
110,282
-2,342
-2% -$165K 1.82% 4
2018
Q3 		$7.62M Buy
112,624
+75,070
+200% +$4.78M 1.1% 14
2018
Q2 		$2.17M Buy
37,554
+737
+2% +$41.6K 0.29% 150
2018
Q1 		$1.91M Buy
+36,817
New +$1.99M 0.24% 150
2017
Q4 		– Sell
-116,171
Closed -$7.1M – 179
2017
Q3 		$7.1M Sell
116,171
-13,948
-11% -$846K 0.76% 45
2017
Q2 		$7.96M Buy
130,119
+55,122
+73% +$3.36M 0.83% 37
2017
Q1 		$4.55M Sell
74,997
-1,294
-2% -$78.5K 0.5% 73
2016
Q4 		$4.29M Buy
76,291
+13,365
+21% +$782K 0.43% 78
2016
Q3 		$3.75M Sell
62,926
-22,348
-26% -$1.31M 0.39% 99
2016
Q2 		$4.69M Sell
85,274
-10,558
-11% -$562K 0.55% 56
2016
Q1 		$4.84M Buy
95,832
+2,910
+3% +$143K 0.6% 52
2015
Q4 		$4.38M Hold
92,922
– – 0.58% 64
2015
Q3 		$4.38M Buy
92,922
+9,451
+11% +$502K 0.57% 65
2015
Q2 		$4.53M Buy
83,471
+13,801
+20% +$774K 0.53% 61
2015
Q1 		$3.82M Buy
69,670
+5,299
+8% +$300K 0.41% 76
2014
Q4 		$3.49M Buy
64,371
+5,474
+9% +$305K 0.42% 80
2014
Q3 		$3.33M Buy
58,897
+339
+0.6% +$19K 0.35% 90
2014
Q2 		$3.23M Buy
58,558
+23,937
+69% +$1.31M 0.31% 92
2014
Q1 		$1.88M Buy
34,621
+896
+3% +$46.4K 0.19% 118
2013
Q4 		$1.61M Buy
33,725
+22,323
+196% +$1.02M 0.14% 142
2013
Q3 		$519K Buy
11,402
+5,921
+108% +$270K 0.06% 218
2013
Q2 		$243K Buy
+5,481
New +$245K 0.03% 220

Other funds holding MRK

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Northpointe Capital's MRK Position: Q3 2019 in Review

Northpointe Capital reduced its Merck (MRK) stake by 34% in Q3 2019, selling an estimated $1.79M and leaving 44,035 shares worth $3.54M. The position accounts for 1.37% of the portfolio, ranked #30.

Northpointe Capital first reported a position in MRK in Q2 2013 and has held it in 25 quarters since. The position peaked at $8.71M in Q1 2019. 2,305 funds tracked by Wall St. Rank hold MRK as of Q3 2019.

  • Northpointe Capital held 44,035 shares of Merck worth $3.54M as of Q3 2019.
  • Northpointe Capital sold 22,322 Merck shares in Q3 2019, an estimated $1.79M.
  • Merck made up 1.37% of Northpointe Capital's portfolio in Q3 2019, its #30 holding.
  • Northpointe Capital first reported a position in Merck in Q2 2013 and has held it in 25 quarters since.
  • Northpointe Capital's Merck position peaked at $8.71M in Q1 2019.
  • 2,305 funds tracked by Wall St. Rank held Merck as of Q3 2019.

Based on Northpointe Capital's 13F filing for Q3 2019, filed 16 Oct 2019.